Please ensure Javascript is enabled for purposes of website accessibility

Why Mallinckrodt, Tenet Healthcare, and AES Jumped Today

By Dan Caplinger - Feb 27, 2018 at 3:31PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out how these stocks bucked a tough market.

The stock market gave up ground on Tuesday as investors reacted negatively to initial testimony from new Federal Reserve Chair Jerome Powell that suggested the central bank might seek to raise short-term interest rates more quickly than some had anticipated. Major benchmarks fell more than 1% on the news, giving up only a portion of their gains from the past several trading sessions. Moreover, some stocks managed to post solid advances despite the downward pressure on the overall market. Mallinckrodt (MNK), Tenet Healthcare (THC 4.47%), and AES (AES 3.48%) were among the best performers on the day. Here's why they did so well.

Mallinckrodt moves forward

Shares of Mallinckrodt jumped 15% after the drug company reported its fourth-quarter financial results. The drugmaker said that net sales fell almost 5% compared to the previous year's quarter, but CEO Mark Trudeau highlighted the progress that Mallinckrodt has made in seeking to focus itself more squarely on specialty pharmaceuticals. By going beyond its generics business, Mallinckrodt hopes to be able to tap into innovation in the pharmaceutical industry, and the company outlined further efforts it plans to take in 2018 that made shareholders excited about the future. Given the pressure that it has felt from balance sheet concerns and competitive forces in the industry, the report came as good news for Mallinckrodt.

Person wearing blue gloves sorting through prescription drug pills.

Image source: Getty Images.

Tenet heals itself

Tenet Healthcare stock climbed 9% in the wake of the company's fourth-quarter financial report. The hospital operator said that revenue moved higher by a larger margin than most had expected, and despite one-time charges, adjusted earnings were strong. Better Medicare reimbursement rates led the company to boost its fiscal 2018 projections for earnings, and it's evident that efforts that Tenet has taken to try to make itself more financially efficient are paying dividends. Concerns remain for the for-profit industry as a whole, but today's results at least allayed immediate fears about Tenet's standing among its peers.

AES powers up

Finally, shares of AES picked up more than 7.5%. The power generation and distribution business said that 2017 earnings climbed roughly 15% on an adjusted basis for the full year, pointing specifically to the company's strategic business unit in the Mexico, Central America, and Caribbean region. AES made huge progress over the past year in making a transition in its energy sourcing, replacing 4.3 gigawatts of coal-fired capacity with 2.3 gigawatts of acquisitions of renewable energy. Favorable expectations for 2018 and future years were also met with a positive response from shareholders, and AES is doing a good job of staying on the cutting edge of the power industry.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tenet Healthcare Corp. Stock Quote
Tenet Healthcare Corp.
$58.24 (4.47%) $2.49
The AES Corporation Stock Quote
The AES Corporation
$21.42 (3.48%) $0.72
Mallinckrodt Public Limited Company Stock Quote
Mallinckrodt Public Limited Company

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.